Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Infection
Published in: Infection 3/2012

01-06-2012 | Case Report

Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade

Authors: J. Llenas-García, A. Lalueza-Blanco, M. Fernández-Ruiz, J. Villar-Silva, M. Ochoa, F. Lozano, M. Lizasoain, J. M. Aguado

Published in: Infection | Issue 3/2012

Login to get access

Abstract

Cardiac tamponade constitutes an exceptional form of actinomycosis. We describe a case of primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade in a 20-year-old patient with previous esophagectomy and colonic interposition, successfully managed by computed tomography-guided percutaneous drainage and a prolonged course of antibiotic treatment. Actinomyces israelii was identified in the pericardial fluid by 16S rRNA gene sequencing. The literature on the simultaneous presentation of cardiac and hepatic actinomycosis is reviewed.
Literature
1.
Yildiz O, Doganay M. Actinomycoses and Nocardia pulmonary infections. Curr Opin Pulm Med. 2006;12:228–34.PubMedCrossRef
2.
3.
4.
Kanellopoulou T, Alexopoulou A, Tanouli MI, Tiniakos D, Giannopoulos D, Koskinas J, Archimandritis AJ. Primary hepatic actinomycosis. Am J Med Sci. 2010;339:362–5.PubMed
5.
Orloff JJ, Fine MJ, Rihs JD. Acute cardiac tamponade due to cardiac actinomycosis. Chest. 1988;93:661–3.PubMedCrossRef
6.
Fife TD, Finegold SM, Grennan T. Pericardial actinomycosis: case report and review. Rev Infect Dis. 1991;13:120–6.PubMedCrossRef
7.
Litwin KA, Jadbabaie F, Villanueva M. Case of pleuropericardial disease caused by Actinomyces odontolyticus that resulted in cardiac tamponade. Clin Infect Dis. 1999;29:219–20.PubMedCrossRef
8.
Jánoskuti L, Lengyel M, Fenyvesi T. Cardiac actinomycosis in a patient presenting with acute cardiac tamponade and a mass mimicking pericardial tumour. Heart. 2004;90:e27.PubMedCrossRef
9.
Acevedo F, Baudrand R, Letelier LM, Gaete P. Actinomycosis: a great pretender. Case reports of unusual presentations and a review of the literature. Int J Infect Dis. 2008;12:358–62.PubMedCrossRef
10.
Chao CT, Liao CH, Lai CC, Hsueh PR. Liver abscess due to Actinomyces odontolyticus in an immunocompetent patient. Infection. 2011;39:77–9.PubMedCrossRef
11.
Kasano Y, Tanimura H, Yamaue H, Hayashido M, Umano Y. Hepatic actinomycosis infiltrating the diaphragm and right lung. Am J Gastroenterol. 1996;91:2418–20.PubMed
12.
Esposti D, Lippolis A, Cipolla M, Bonazzi M. An uncommon cause of pericardial actinomycosis. Ital Heart J. 2000;1:632–5.PubMed
13.
Makaryus AN, Latzman J, Yang R, Rosman D. A rare case of Actinomyces israelii presenting as pericarditis in a 75-year-old man. Cardiol Rev. 2005;13:125–7.PubMedCrossRef
14.
von Graevenitz A. Actinomyces neuii: review of an unusual infectious agent. Infection. 2011;39:97–100.CrossRef
Metadata
Title
Primary hepatic actinomycosis presenting as purulent pericarditis with cardiac tamponade
Authors
J. Llenas-García
A. Lalueza-Blanco
M. Fernández-Ruiz
J. Villar-Silva
M. Ochoa
F. Lozano
M. Lizasoain
J. M. Aguado
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Infection / Issue 3/2012
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0200-y

Other articles of this Issue 3/2012

Infection 3/2012 Go to the issue

Case Report

Rat bite fever as a presenting illness in a patient with AIDS

Clinical and Epidemiological Study

Changing epidemiology of methicillin-resistant Staphylococcus aureus in the Veterans Affairs Healthcare System, 2002–2009

Clinical and Epidemiological Study

Cryptosporidium gastroenteritis in Egyptian children with acute lymphoblastic leukemia: magnitude of the problem

Case Report

Successful tigecycline lock therapy in a Lactobacillus rhamnosus catheter-related bloodstream infection

Case Report

Fusobacterium nucleatum prosthetic hip infection in an adult with sickle cell-beta thalassemia

Clinical and Epidemiological Study

Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits